Stockreport

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Bioverativ Inc. to Sanofi for $105 Per Share is Fair to Shareholders

BIOVERATIV INC COMMON  (BIVV) 
Last bioverativ inc common earnings: 2/13 04:15 pm Check Earnings Report
PDF NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Bioverativ [Read more]